age1 logo

age1

North America, California, United States, San Francisco

Description

Age1 is a venture capital firm that primarily invests in biotechnology companies.

Investor Profile

age1 has backed more than 1 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does age1 frequently co-invest with?

Modi Ventures
North America, Texas, United States, Houston
Co-Investments: 1
Rock Creek Capital
North America, Florida, United States, Jacksonville
Co-Investments: 1
Felicis
North America, California, United States, Menlo Park
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does age1 often collaborate with?

JD
North America, California, United States, Palo Alto
Shared Deals: 1
JB
North America, California, United States, Palo Alto
Shared Deals: 1
UL
North America, California, United States, San Francisco
Shared Deals: 1
AN
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
TM
North America, California, United States, San Francisco
Shared Deals: 1
NB
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by age1?

Skeletalis

Boston, Massachusetts, United States

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

BiotechnologyHealth CarePharmaceutical
SeedNov 17, 2025
Amount Raised: $8,000,000
Aerska

Dublin, Dublin, Ireland

Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders.

Biotechnology
SeedOct 1, 2025
Amount Raised: $21,000,000
General Proximity

San Francisco, California, United States

General Proximity is a pioneering future-oriented proximity medicine that envisions the future of medicine.

BiotechnologyMedical
SeedJan 3, 2025
Amount Raised: $16,000,000